⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
Global Procurement Awards 2026 Shortlist Announced
globenewswire.com
AAL
BMY
PEP
Malignant Pleural Effusion Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
CRSP
MRK
NVS
BMY
AZN
PFE
REGN
PharmaBlock réunit à Zurich les leaders mondiaux du secteur afin de faire progresser la chimie verte au service d'une production pharmaceutique durable
prnewswire.com
NVS
PFE
BMY
SNY
AZN
Neo Launches with $100M to Secure AI Software Across the Enterprise
globenewswire.com
S
PANW
SHOP
NVDA
MSFT
GOOG
AMZN
CRM
ADBE
IBM
INTC
AMD
QCOM
META
TWLO
LI
CVNA
DDOG
CRWD
OKTA
PLTR
SNOW
SMCI
MU
AMAT
LRCX
ASML
ORCL
SAP
CSCO
FTNT
CHKP
VRTX
REGN
GILD
BIIB
AZN
PFE
MRNA
BMY
AMGN
LLY
ABBV
NVO
SNPS
CDNS
MCHP
NXPI
ON
ADI
TXN
CRSP
EXAS
ALGN
TDOC
ROKU
COIN
PYPL
HOOD
Cell and Gene Therapy Global Market Opportunities And Strategies To 2035 Published — Analyzes Hospitals, Cancer Care Centers and Other End Users
globenewswire.com
GILD
NVS
BMY
JNJ
SRPT
VRTX
AMGN
Septa Pharmaceuticals Inc. erwirbt CeeNU®- e (Lomustin) von Bristol Myers Squibb, Kanada
prnewswire.com
BMY
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
prnewswire.com
BMY
Septa Pharmaceuticals Inc. acquiert l' e CeeNU® (lomustine) auprès de Bristol Myers Squibb Canada
prnewswire.com
BMY